Your browser doesn't support javascript.
loading
Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.
Nishimura, Akira; Aoki, Yuki; Ishiwata, Yasuyoshi; Ichimura, Takuya; Ueyama, Junichi; Kawahara, Yuta; Tomoda, Takahiro; Inoue, Maiko; Matsumoto, Kazuaki; Inoue, Kento; Hiroki, Haruka; Ono, Shintaro; Yamashita, Motoi; Okano, Tsubasa; Tanaka-Kubota, Mari; Ashiarai, Miho; Miyamoto, Satoshi; Miyawaki, Reiji; Yamagishi, Chika; Tezuka, Mari; Okawa, Teppei; Hoshino, Akihiro; Endo, Akifumi; Yasuhara, Masato; Kamiya, Takahiro; Mitsuiki, Noriko; Ono, Toshiaki; Isoda, Takeshi; Yanagimachi, Masakatsu; Tomizawa, Daisuke; Nagasawa, Masayuki; Mizutani, Shuki; Kajiwara, Michiko; Takagi, Masatoshi; Kanegane, Hirokazu; Imai, Kohsuke; Morio, Tomohiro.
Afiliación
  • Nishimura A; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Aoki Y; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ishiwata Y; Department of Hospital Pharmacy, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ichimura T; Department of Pediatrics, Yamaguchi University Hospital, Yamaguchi, Japan.
  • Ueyama J; Department of Pediatrics, Tottori University Hospital, Tottori, Japan.
  • Kawahara Y; Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan.
  • Tomoda T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Inoue M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Matsumoto K; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Inoue K; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Hiroki H; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ono S; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Yamashita M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Okano T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanaka-Kubota M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ashiarai M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Miyamoto S; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Miyawaki R; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Yamagishi C; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tezuka M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Okawa T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Hoshino A; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Endo A; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Yasuhara M; Department of Pharmacokinetics and Pharmacodynamics, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Kamiya T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Mitsuiki N; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ono T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Isoda T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Yanagimachi M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tomizawa D; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Nagasawa M; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Mizutani S; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Kajiwara M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Takagi M; Department of Transfusion Medicine and Cell Therapy, Tokyo Medical and Dental University (TMDU), Medical Hospital, Tokyo, Japan.
  • Kanegane H; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Imai K; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Morio T; Department of Child Health and Development, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
J Clin Immunol ; 41(5): 944-957, 2021 07.
Article en En | MEDLINE | ID: mdl-33527309

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vidarabina / Busulfano / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Enfermedades de Inmunodeficiencia Primaria / Inmunosupresores / Melfalán Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Clin Immunol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vidarabina / Busulfano / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Enfermedades de Inmunodeficiencia Primaria / Inmunosupresores / Melfalán Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Clin Immunol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos